The Europe collagen peptides market size is expected to be worth US$ 0.56 billion in 2024 and is estimated to reach a valuation of US$ 1.35 billion by the end of 2032 with a noteworthy growth rate of 11.66% between 2024 and 2032
Collagen peptides are bioactive peptides derived from the enzymatic hydrolysis process of collagen. Collagen peptides, also known as hydrolyzed collagen, are highly digestible, cold-soluble, and biologically available sources of collagen. Collagen peptides are short chains of amino acids that are obtained naturally from collagen proteins. This collagen peptide dissolves in cold water, is well digested, and has high bioavailability. It is a good source of protein and healthy nutrition that can help improve joint health, prevent bone loss, reduce skin wrinkles and improve moisture levels, improving overall skin health. The intake of collagen ensures the elasticity, aggregation and regeneration of hair, skin, cartilage, tendons, joints and bones. The production of collagen peptides is mainly limited to developed countries such as the Italy, Germany, and the United Kingdom. This is because collagen extraction requires advanced technology that is currently impossible in developing countries. The increasing demand for collagen peptides is expected to drive the growth of the European collagen peptides market in the near future.
The Europe collagen peptide industry is seeing great opportunities as concerns about the health increase. Busy work schedules increase the intake of on-the-go meals. Other than that, increased health awareness and consumer income has also increased the trade in Europe collagen peptides as a functional ingredient. Also, increased consumption in developed countries such as dairy products, snacks and bakeries is expected to drive market growth. Food safety laws and even the health risks of synthetic and artificial ingredients have helped inform consumers of the benefits of collagen peptides in food and beverage products. Growing consumer awareness of personal health care around the region has had a major impact on the market in recent years. Along with this, the increasing demand for collagen peptides in wound healing and other regenerative drugs are driving the growth of this market significantly. This demand is mainly due to the fact that collagen peptides are the main functional food ingredient in many foods. The growing call for collagen peptides in the food and beverage sector will be the main driver of European market during the forecast period. This increase in demand is expected to drive market growth primarily in forecast time, as collagen products are a high source of protein and play an important role in body nutrition. Additionally, increased awareness of health awareness driving the consumption of nutritional products is expected to increase the need for collagen peptides. Especially in developing countries, the increased impact of preventive medicine coupled with the use of dietary supplements will drive the growth of the collagen peptides market.
Along with the change in lifestyle and prices of urbanization, the high dependence on cosmeceutical and diet products may influence the trend of collagen peptide market prices. Cultural issues related to fluctuating pH characteristics, photoaging of the skin, and sources of collagen are challenging factors for product demand. Additionally, the growth of the Europe food processing industry and the rise of common lifestyle diseases have led to a paradigm shift among consumers who currently prefer functional foods. Besides, increased awareness of the nutritional benefits of dietary supplements is expected to increase the demand for Europe collagen peptides worldwide. In addition, the rising need for dietary supplements, the increased use of collagen in the food and beverage industry, the propensity of consumers for a healthy, protein-rich diet, and an increased application of collagen peptides in nutritional cosmetics, pharmaceuticals and healthcare are driving the Europe market for collagen peptides. Furthermore, the use of collagen for wound healing is one of the key trends associated with the market due to the increasing obesity and elderly population in the region. The increasing investment in R&D activities for the synthesis of plant-based collagen and gelatin and the increasing number of manufacturers are expected to provide profitable opportunities in the coming years.
Furthermore, a strict regulatory framework regarding the extraction of collagen of animal origin is hampering the growth of the Europe Collagen Peptides market.
The peptides obtained from cattle and pigs dominated the regional and international marketplace. The health benefits and cost effectiveness associated with animal collagen peptides are the main reasons why consumers prefer them.
The nutritional products segment had the largest market share in 2019 due to the increasing demand for sports nutrition products that promote muscle growth and increase bone and joint related problems in an aging population. Collagen peptides are also considered an important nutritional component in most protein products because they improve athletic performance and reduce the risk of injury.
Europe is also expected to grow at a faster pace in the market in the future, with the presence of a variety of major nutritional product research institutions and the significant development of the pharmaceutical and food and beverage industries. The European region is dominant in several countries, including Germany and the United Kingdom, as the call for fitness supplements increases among athletes due to healthy living, augmenting demand for collagen. With the increasing use of collagen peptides in the cosmetic industry, the increasing awareness of health is driving the growth of this market mainly in Europe.
Major Key Players in the Europe Collagen Peptides Market are Cargill, GELITA AG, Rousselot, Roxlor LLC, InterHealth Nutraceuticals, ItalgelatineSpA, Kewpie Corporation, LapiGelatine, HolistaColltech Limited , Gelnex, Danish Crown A/S, Weishardt Group, and Tessenderlo Group
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region